These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25749978)

  • 1. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.
    Mori M; Kovalenko L; Lyonnais S; Antaki D; Torbett BE; Botta M; Mirambeau G; Mély Y
    Curr Top Microbiol Immunol; 2015; 389():53-92. PubMed ID: 25749978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.
    Humbert N; Kovalenko L; Saladini F; Giannini A; Pires M; Botzanowski T; Cherenok S; Boudier C; Sharma KK; Real E; Zaporozhets OA; Cianférani S; Seguin-Devaux C; Poggialini F; Botta M; Zazzi M; Kalchenko VI; Mori M; Mély Y
    ACS Infect Dis; 2020 Apr; 6(4):687-702. PubMed ID: 32045204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
    Mori M; Kovalenko L; Malancona S; Saladini F; De Forni D; Pires M; Humbert N; Real E; Botzanowski T; Cianférani S; Giannini A; Dasso Lang MC; Cugia G; Poddesu B; Lori F; Zazzi M; Harper S; Summa V; Mely Y; Botta M
    ACS Chem Biol; 2018 Jan; 13(1):253-266. PubMed ID: 29235845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.
    Mori M; Nucci A; Lang MC; Humbert N; Boudier C; Debaene F; Sanglier-Cianferani S; Catala M; Schult-Dietrich P; Dietrich U; Tisné C; Mely Y; Botta M
    ACS Chem Biol; 2014 Sep; 9(9):1950-5. PubMed ID: 24988251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the viral nucleocapsid protein in anti-HIV-1 therapy.
    de Rocquigny H; Shvadchak V; Avilov S; Dong CZ; Dietrich U; Darlix JL; Mély Y
    Mini Rev Med Chem; 2008 Jan; 8(1):24-35. PubMed ID: 18220982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Gorelick RJ; Gagliardi TD; Bosche WJ; Wiltrout TA; Coren LV; Chabot DJ; Lifson JD; Henderson LE; Arthur LO
    Virology; 1999 Mar; 256(1):92-104. PubMed ID: 10087230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.
    Garg D; Torbett BE
    Virus Res; 2014 Nov; 193():135-43. PubMed ID: 25026536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein.
    Kim MJ; Kim SH; Park JA; Yu KL; Jang SI; Kim BS; Lee ES; You JC
    Retrovirology; 2015 Nov; 12():90. PubMed ID: 26545586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the inhibition mechanism of HIV-1 nucleocapsid protein chaperone activities by methylated oligoribonucleotides.
    Avilov SV; Boudier C; Gottikh M; Darlix JL; Mély Y
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1010-8. PubMed ID: 22083480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
    Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging.
    Kafaie J; Song R; Abrahamyan L; Mouland AJ; Laughrea M
    Virology; 2008 Jun; 375(2):592-610. PubMed ID: 18343475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS.
    McDonnell NB; De Guzman RN; Rice WG; Turpin JA; Summers MF
    J Med Chem; 1997 Jun; 40(13):1969-76. PubMed ID: 9207937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific zinc-finger architecture required for HIV-1 nucleocapsid protein's nucleic acid chaperone function.
    Williams MC; Gorelick RJ; Musier-Forsyth K
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8614-9. PubMed ID: 12084921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid kinetics of protein-nucleic acid interaction is a major component of HIV-1 nucleocapsid protein's nucleic acid chaperone function.
    Cruceanu M; Gorelick RJ; Musier-Forsyth K; Rouzina I; Williams MC
    J Mol Biol; 2006 Nov; 363(5):867-77. PubMed ID: 16997322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein.
    Gamba E; Mori M; Kovalenko L; Giannini A; Sosic A; Saladini F; Fabris D; Mély Y; Gatto B; Botta M
    Eur J Med Chem; 2018 Feb; 145():154-164. PubMed ID: 29324338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.
    Guo J; Wu T; Kane BF; Johnson DG; Henderson LE; Gorelick RJ; Levin JG
    J Virol; 2002 May; 76(9):4370-8. PubMed ID: 11932404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1.
    Summers MF; Henderson LE; Chance MR; Bess JW; South TL; Blake PR; Sagi I; Perez-Alvarado G; Sowder RC; Hare DR
    Protein Sci; 1992 May; 1(5):563-74. PubMed ID: 1304355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein.
    Mori M; Ciaco S; Mély Y; Karioti A
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleocapsid Annealing-Mediated Electrophoresis (NAME) assay allows the rapid identification of HIV-1 nucleocapsid inhibitors.
    Sosic A; Cappellini M; Scalabrin M; Gatto B
    J Vis Exp; 2015 Jan; (95):52474. PubMed ID: 25650789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.